InMed Pharmaceuticals

INMNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.122 M

$1.47 +2.80%

Close of 7 Aug 2026

Revenue

$4.94M

#3302 by revenue

Earnings

-$8.16M

Loss-making

Shares outstanding

3,314,063

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#479Transcode TherapeuticsRNAZ$4.19M
#480PMGCELAB$4.16M
#481InMed PharmaceuticalsINM$4.12M
#482SciSparcSPRC$3.97M
#483XORTX TherapeuticsXRTX$3.69M

Where these numbers come from

Share counts and financials for InMed Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.